Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genmab A/S
Income from Continuing Operations Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Income from Continuing Operations
kr5.5B
CAGR 3-Years
30%
CAGR 5-Years
36%
CAGR 10-Years
45%
Zealand Pharma A/S
CSE:ZEAL
Income from Continuing Operations
-kr712m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
-22%
Ascendis Pharma A/S
NASDAQ:ASND
Income from Continuing Operations
-€489.5m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Income from Continuing Operations
kr707.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fluoguide AS
STO:FLUO
Income from Continuing Operations
-kr38.4m
CAGR 3-Years
-30%
CAGR 5-Years
-273%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Income from Continuing Operations
-kr50m
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
-10%

See Also

What is Genmab A/S's Income from Continuing Operations?
Income from Continuing Operations
5.5B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Income from Continuing Operations amounts to 5.5B DKK.

What is Genmab A/S's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
45%

Over the last year, the Income from Continuing Operations growth was 16%. The average annual Income from Continuing Operations growth rates for Genmab A/S have been 30% over the past three years , 36% over the past five years , and 45% over the past ten years .

Back to Top